cnbc semaglutide Novo Nordisk’s latest obesity drug trial disappoints, sending shares tumbling. CNBC’s Charlotte Reed investigates the setback. | International CNBC-TV18's Video on X
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31















![Ozempic Lawsuit [July 2026 Update]](https://www.torhoermanlaw.com/wp-content/uploads/2024/05/TorHoerman-Law_-Accepting-Clients-for-the-Ozempic-Lawsuit.jpg)









